<code id='74C418A403'></code><style id='74C418A403'></style>
    • <acronym id='74C418A403'></acronym>
      <center id='74C418A403'><center id='74C418A403'><tfoot id='74C418A403'></tfoot></center><abbr id='74C418A403'><dir id='74C418A403'><tfoot id='74C418A403'></tfoot><noframes id='74C418A403'>

    • <optgroup id='74C418A403'><strike id='74C418A403'><sup id='74C418A403'></sup></strike><code id='74C418A403'></code></optgroup>
        1. <b id='74C418A403'><label id='74C418A403'><select id='74C418A403'><dt id='74C418A403'><span id='74C418A403'></span></dt></select></label></b><u id='74C418A403'></u>
          <i id='74C418A403'><strike id='74C418A403'><tt id='74C418A403'><pre id='74C418A403'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:12532
          Cambridge: AbbVie
          Ruby Wallau for STAT

          AbbVie will pay $10 billion for the biotech firm Immunogen, the company said Thursday, acquiring an approved treatment for ovarian cancer and buying into a burgeoning area of oncology.

          Under the agreement, AbbVie will pay $31.26 per share in cash for Immunogen, a nearly 100% premium to the company’s recent trading price. Central to the deal, expected to close in the middle of next year, is Elahere, an Immunogen product that won Food and Drug Administration approval for advanced ovarian cancer in 2022.

          advertisement

          Elahere is among a surging class of cancer medicines called antibody-drug conjugates, or ADCs, which are designed to deliver a targeted dose of chemotherapy directly to tumor cells while sparing healthy tissues. AbbVie’s acquisition is the latest multibillion-dollar deal in the space, following Merck’s $22 billion agreement with ADC specialist Daiichi Sankyo and Pfizer’s $43 billion buyout of Seagen earlier this year.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more
          Sudafed saga points to U.S. issues with evaluating older drugs
          Sudafed saga points to U.S. issues with evaluating older drugs

          PATRICKT.FALLON/AFPviaGettyImagesYouwouldhavebeenforgivenforbeingsurprisedonSept.12whenapanelofadvis

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          White House Covid adviser calls on docs to combat misinformation

          AshishJha,coordinatoroftheWhiteHouseCovidresponseteamBRENDANSMIALOWSKI/AFPviaGettyImagesWALTHAM,Mass